We use essential cookies to make our site work. With your consent, we may also use non-essential cookies to improve user experience and analyze website traffic. By clicking “Accept,” you agree to our website's cookie use as described in our Cookie Policy. You can change your cookie settings at any time by clicking “Preferences.”
About

Market Analysis

44%
F&G: 43
MID CYCLEYield: 0.65%
With the US market open but live, verifiable real-time data not accessible in this context, the focus shifts from today’s specific price moves to the enduring forces that drive intraday volatility—earnings results, economic releases, interest-rate expectations, and global risk sentiment. A well-constructed portfolio emphasizes diversification across asset classes, sectors, and styles; integrates disciplined risk management; and uses volatility to rebalance and improve quality rather than to chase short-term swings. This approach can be narrated directly into a video script, guiding investors through what typically moves markets during an active trading session and how to position portfolios for a range of outcomes without relying on any single data point or headline.

Market Pulse

44% advancingMID CYCLE phase
retail 1.59%, advertising 1.10%contract -1.74%, commodity -0.71%

Fear & Greed

43fear

Outlook

Global Economic Rebound 30%China-Led Global Growth 25%Stagflationary Environment 20%

Sectors

Energy 1.90%, Health Care 1.57%Materials -1.71%, Technology -1.02%

Bonds

3M:3.84%10Y:4.49%
Slope:0.65%(normal)

News

Scully Royalty Board of Directors and Management Remain Unchanged
Scully Royalty Board of Directors and Management Remain Unchanged
📊Thesis Ideas Based on Market Conditions
🔄 AI Megacap Selloff Sparks Rotation Into Cyclicals and Small Caps
🌍 Defense Stocks Extend Outperformance as Geopolitical Tensions Stay Elevated
🏦 Sticky US Inflation Keeps Fed Cautious, Pressuring Long-Duration Growth
📉 Rising Crude and Geopolitical Risk Support Energy While Squeezing Transport Margins
🔄 US Small Caps Extend Outperformance as Market Breadth Widens
📊 Micron-Led Chip Selloff Marks New Volatility Phase for AI Hardware Trade
🔄 AI Megacap Selloff Sparks Rotation Into Cyclicals and Small Caps
🌍 Defense Stocks Extend Outperformance as Geopolitical Tensions Stay Elevated
🏦 Sticky US Inflation Keeps Fed Cautious, Pressuring Long-Duration Growth
📉 Rising Crude and Geopolitical Risk Support Energy While Squeezing Transport Margins
🔄 US Small Caps Extend Outperformance as Market Breadth Widens
📊 Micron-Led Chip Selloff Marks New Volatility Phase for AI Hardware Trade
Date
Company
Employee Outlook
Market Cap
Growth
Short %
Signals
Analysts Rating
Industry
Economic Events:
Sentiment:10%
Healthcare and biopharma companies benefiting from policy clarity, accelerating M&A activity, AI-enhanced drug discovery, and attractive valuations as capital rotates from concentrated mega-cap AI leaders seeking defensive positioning.+1.1%7↑ / 4↓     
Jul 15
7 days
Johnson & Johnson logo
Johnson & Johnson (JNJ)
jnj.com
0.70 +0%$643.30B6.80%1.00%2.0 BuyDrug Manufacturers - General
Jul 16
8 days
UnitedHealth Group Incorporated logo
UnitedHealth Group Incorporated (UNH)
unitedhealthgroup.com
0.47 -7%$388.86B12.20%1.54%1.6 BuyHealthcare Plans
Jul 29
21 days
Biogen Inc. logo
Biogen Inc. (BIIB)
biogen.com
0.48 +11%$31.01B2.80%5.97%2.0 BuyDrug Manufacturers - General
Jul 30
22 days
Alnylam logo
Alnylam (ALNY)
alnylam.com
0.69 -6%$42.94B96.40%5.39%1.8 BuyBiotechnology
Jul 30
22 days
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc. (REGN)
regeneron.com
$70.26B19.00%2.84%
1.7 BuyBiotechnology
Jul 31
23 days
AbbVie Inc. logo
AbbVie Inc. (ABBV)
abbvie.com
0.75 -2%$449.93B12.40%1.42%1.7 BuyDrug Manufacturers - General
Jul 31
23 days
Moderna logo
Moderna (MRNA)
modernatx.com
$31.65B-45.40%21.26%3.0 HoldBiotechnology
Aug 3
26 days
Vertex Pharmaceuticals Incorpor logo
Vertex Pharmaceuticals Incorpor (VRTX)
vrtx.com
0.81 -5%$132.18B11.00%1.97%1.6 BuyBiotechnology
Aug 4
27 days
Amgen Inc. logo
Amgen Inc. (AMGN)
amgen.com
0.70 +0%$198.67B8.60%2.67%2.4 BuyDrug Manufacturers - General
Aug 6
29 days
Gilead logo
Gilead (GILD)
gilead.com
$169.30B3.00%1.75%
1.7 BuyDrug Manufacturers - General
Aug 9
Estimated earnings date32 days
CRISPR logo
CRISPR (CRSP)
crisprtx.com
0.43 +0%$5.98B47.70%25.76%2.0 BuyBiotechnology